Epithelial Mesenchymal Interactions in Lung Development and Fibrosis Conference is organized by Fusion Conferences Ltd and will be held during Feb 17 - 20, 2019 at Melia Nassau Beach All Inclusive, Nassau, New Providence, Bahamas. The target audience for this medical event is Pathologists.
Lung development is governed by epithelial-mesenchymal interactions. These pathways are recapitulated during injury and repair. This conference will focus on understanding key processes underlying lung development, injury and repair in the context of age, environment and species, with the hope of better understanding disease development and to discover novel therapeutic approaches.
We will highlight critical issues on lung epithelial biology such as stem cells and regenerative medicine, while expanding sessions to encompass themes such as single cell analytical approaches, cell-cell communication, dissect the biological distinctions mesenchymal proliferation as a repair mechanism and fibrosis; present the impact of new tools in single-cell analysis on understanding lung development, repair, and disease; and characterize epithelial-mesenchymal interrelationships that maintain lung homeostasis and orchestrate repair and regeneration. The entire program has been designed to achieve a better understanding of the key clinical research issues and how they relate to basic mechanistic investigation.
• Fgf signaling in lung development and fibrosis
• Aging and lung fibrosis
• Lung stem/progenitor cells and their regulation in health and disease
• Organoid cultures to model lung development and disease
• Epithelial-mesenchymal interactions in lung development and fibrosis
Time: 2:00 pm to 12:00 pm
Academic from: USD 1822.0,
Industry from: USD 1822.0,
Student from: USD 1533.0
Speakers: Saverio Bellusci (University of Giessen), Zea Borok (Keck School of Medicine of USC), Wellington Cardoso (Columbia University), Gianni Carraro (Cedars-Sinai), Harold Chapman (University of California, San Francisco), Elie El Agha (Justus-Liebig-University Giessen), John Engelhardt (University of Iowa Carver College of Medicine), Finn Hawkins (Boston University), Brigid Hogan (Duke University), Alison Humbles (MedImmune LLC), Carla Kim (Harvard Medical School), Melanie Koenigshoff (University of Colorado Denver), Mark Krasnow (Stanford University), Maya Kumar (Stanford School of Medicine), Daniel Lafkas (Genentech), Susan Majka (Vanderbilt University), Parviz Minoo (Keck School of Medicine of USC), Edward Morrisey (University of Pennsylvania), Paul Noble (Cedars-Sinai), David Ornitz (Washington University), Anne-Karina Perl (Cincinnati Children's Hospital), Jayaraj Rajagopal (Harvard University), Emma Rawlins (University of Cambridge), Jason Rock (Boston University), Jason Spence (University of Michigan), Xin Sun (University of California, San Diego), Nan Tang (National Institute of Biological Sciences), Victor Thannickal (University of Alabama at Birmingham), David Warburton (Keck School of Medicine of USC), Rui Zhao (Novartis)
Additional details will be posted as soon as they are available.